1. Home
  2. PAVS vs ENTX Comparison

PAVS vs ENTX Comparison

Compare PAVS & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

N/A

Current Price

$4.03

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$2.85

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAVS
ENTX
Founded
2004
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
147.4M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
PAVS
ENTX
Price
$4.03
$2.85
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
11.2K
★ 389.5K
Earning Date
08-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ 0.22
Revenue
N/A
★ $42,000.00
Revenue This Year
$541.46
N/A
Revenue Next Year
$1.00
N/A
P/E Ratio
★ N/A
$12.05
Revenue Growth
★ N/A
N/A
52 Week Low
$0.02
$0.91
52 Week High
$26.69
$4.20

Technical Indicators

Market Signals
Indicator
PAVS
ENTX
Relative Strength Index (RSI) 39.15 51.28
Support Level $3.86 $2.71
Resistance Level $5.55 $3.12
Average True Range (ATR) 0.23 0.18
MACD 0.01 -0.02
Stochastic Oscillator 10.00 56.14

Price Performance

Historical Comparison
PAVS
ENTX

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: